In light of new FDA labeling recommendations for saline and silicone gel-filled breast implants, FDA officials Amy Abernethy and Jeffrey E. Shuren issued a statement outlining the agency’s recommendations for manufacturers.
Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.
